ES2079348T3 - Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida. - Google Patents

Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida.

Info

Publication number
ES2079348T3
ES2079348T3 ES87401815T ES87401815T ES2079348T3 ES 2079348 T3 ES2079348 T3 ES 2079348T3 ES 87401815 T ES87401815 T ES 87401815T ES 87401815 T ES87401815 T ES 87401815T ES 2079348 T3 ES2079348 T3 ES 2079348T3
Authority
ES
Spain
Prior art keywords
strain
plasmide
contained
stabilization procedure
bacterial strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87401815T
Other languages
English (en)
Inventor
Eric Degryse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8611311A external-priority patent/FR2602792B1/fr
Priority claimed from FR8709935A external-priority patent/FR2618159B2/fr
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of ES2079348T3 publication Critical patent/ES2079348T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO DE ESTABILIZACION DE UN VECTOR PLASMIDICO CONTENIDO EN UNA BACTERIA, CARACTERIZADO EN QUE LA BACTERIA COMPORTA UNA MUTACION CROMOSOMICA DAP- Y EN QUE EL VECTOR PLASMIDO LLEVA UN GEN DAP+.
ES87401815T 1986-08-05 1987-08-05 Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida. Expired - Lifetime ES2079348T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8611311A FR2602792B1 (fr) 1986-08-05 1986-08-05 Procede de stabilisation d'un plasmide contenu dans une souche bacterienne et souche obtenue
FR8709935A FR2618159B2 (fr) 1987-07-15 1987-07-15 Procede de stabilisation d'un plasmide contenu dans une souche bacterienne et souche obtenue

Publications (1)

Publication Number Publication Date
ES2079348T3 true ES2079348T3 (es) 1996-01-16

Family

ID=26225423

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87401815T Expired - Lifetime ES2079348T3 (es) 1986-08-05 1987-08-05 Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida.

Country Status (9)

Country Link
EP (1) EP0258118B1 (es)
JP (3) JP2772793B2 (es)
AT (1) ATE129285T1 (es)
AU (1) AU616637B2 (es)
CA (1) CA1340903C (es)
DE (1) DE3751564T2 (es)
DK (1) DK408687A (es)
ES (1) ES2079348T3 (es)
GR (1) GR3018296T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501351A (ja) * 1987-10-07 1992-03-12 ワシントン ユニバーシティ 細胞の遺伝的集団において所望の組換え遺伝子を維持する方法
JP3078312B2 (ja) * 1990-11-22 2000-08-21 協和醗酵工業株式会社 物質の製造法
TW201794B (es) * 1991-05-03 1993-03-11 American Cyanamid Co
GB9605453D0 (en) 1996-03-15 1996-05-15 Univ Cambridge Tech Cultured cells
EP0972838B1 (en) * 1998-07-15 2004-09-15 Roche Diagnostics GmbH Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
US6291245B1 (en) 1998-07-15 2001-09-18 Roche Diagnostics Gmbh Host-vector system
US6872547B1 (en) * 2000-10-11 2005-03-29 Washington University Functional balanced-lethal host-vector systems
DE102004040134A1 (de) * 2004-08-19 2006-02-23 Henkel Kgaa Neue essentielle Gene von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren
KR101461408B1 (ko) * 2005-10-06 2014-11-13 어드밴스드 엑셀러레이터 어플리케이션즈 에스.에이. 신규 선택 시스템
WO2017101958A1 (en) * 2015-12-18 2017-06-22 Glycom A/S Fermentative production of oligosaccharides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511032B1 (fr) * 1981-08-07 1985-08-09 Centre Nat Rech Scient Nouveaux plasmides et souches bacteriennes transformees et leur application a la synthese de lysine
FR2520753B1 (fr) * 1982-02-01 1986-01-31 Transgene Sa Nouveaux vecteurs d'expression de la catechol 2,3-oxygenase, enzymes obtenues et leurs applications
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
JP2599585B2 (ja) * 1984-06-19 1997-04-09 トランスジ−ン ソシエテ アノニム ヒトα▲下１▼−アンチトリプシン誘導体及びその製造法
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
GB2177097A (en) * 1985-06-18 1987-01-14 Genencor Inc Stable maintenance of nucleic acid in recombinant cells

Also Published As

Publication number Publication date
ATE129285T1 (de) 1995-11-15
DE3751564D1 (de) 1995-11-23
AU616637B2 (en) 1991-11-07
DK408687A (da) 1988-02-06
JPH1066575A (ja) 1998-03-10
JP2844191B2 (ja) 1999-01-06
JP2905921B2 (ja) 1999-06-14
JPS63233790A (ja) 1988-09-29
JP2772793B2 (ja) 1998-07-09
DE3751564T2 (de) 1996-03-28
DK408687D0 (da) 1987-08-05
JPH104981A (ja) 1998-01-13
AU7658987A (en) 1988-02-11
CA1340903C (fr) 2000-02-22
EP0258118B1 (fr) 1995-10-18
EP0258118A1 (fr) 1988-03-02
GR3018296T3 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
ATE256196T1 (de) Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
PT1584682E (pt) Regulação da expressão do gene bcl-2
HUT67762A (en) Polyoxypropylene/polyoxiethylene copolymers with improved biological activity and process for producing thereof
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
ES2008974A6 (es) Formulacion liquida de enzimas para aplicacion tecnica, utilizaciones y procedimientos de empleo para desencalado, adobo, remojo y desengrasado de pieles en tripa.
AU9338598A (en) Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences
ES2079348T3 (es) Procedimiento de estabilizacion de un plasmido contenido en una cepa bacteriana y cepa obtenida.
HUP9904203A2 (hu) Eljárás hosszú, ismétlődő DNS-szekvenciák stabil klónozására
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
DE3478699D1 (en) Method for producing interferons
MY114140A (en) Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy.
EP0574347A3 (es)
IL131014A0 (en) Methods for cultivating cells and propagating viruses
AU1462688A (en) Process for the production of proteins
HU9203644D0 (en) Plasmide stabilizing micro-organism
AU5971090A (en) Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same
AU7514087A (en) Vaccine containing the protein f of the aids virus
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
EP0247145A4 (en) MULTIPLICATION AMPLIFIABLE VECTORS FOR EXPRESSION OF HEXOGENIC DNA IN LARGE QUANTITIES.
EP0220714A3 (en) Dna fragment containing the cyclodextrin-glycosyl-transferase gene, expression vector, microorganisms for expression and preparation process
EP0415958A4 (en) A p1 bacteriophage cloning system for dna fragments as large as 95 kb
TW242161B (es)
WO1993018151A1 (fr) Element transposable originaire d'une bacterie du genre brevibacterium
DK0544250T3 (da) Gen, der koder for esterase, og ny mikroorganisme indeholdende dette gen
AU4496196A (en) Recombinant DNA comprising DNA coding for myosin heavy chain SM1 isoform protein inserted into vector DNA, microorganism carrying the recombinant DNA, and an agent for treatment of arteriosclerosis comprising the recombinant DNA

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 258118

Country of ref document: ES